Multiple Sclerosis Drug OKd by Panel
From Times Staff and Wire Reports
A new drug to help treat multiple sclerosis won unanimous backing from a Food and Drug Administration advisory panel. The panel recommended the approval of Israel’s Teva Pharmaceutical Industries Ltd.’s Copaxone drug. If approved, this would be the third drug available in the United States to treat the disease, for which there is no cure. The disease can be mild or it can cause successive flare-ups, each causing more deterioration of movement, speech and basic bodily functions.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
